Ceragenix Pharmaceuticals

Colorado business, 7/27
Denver Post - Ceragenix Pharmaceuticals Inc. , a Denver-based biopharmaceutical

Research on Use of Ceragenins(TM) As Potential Therapy for Cystic
MSN MoneyCentral - Ceragenix Pharmaceuticals, Inc. a biopharmaceutical company focused on infectious disease and dermatology, today announced that the American Society of Microbiology ("ASM") has accepted nine research abstracts on Ceragenins(TM) as poster

More trauma rooms permit family members' presence
KVOA 4 - NEW YORK, July 13 /PRNewswire-FirstCall/ -- On July 12, Steven Porter, CEO of Ceragenix Pharmaceuticals, Inc. updated the investment community in an exclusive interview with www.wallst.net . Topics covered in the interview include an overview of the

Latest News
dBusinessNews.com - Research on Use of Ceragenins(TM) As Potential Therapy for Cystic Fibrosis Related Infections and Other Diseases to be Presented at ICAAC 2006 DENVER -- Interscience Conference on Antimicrobial Agents and Chemotherapy(ICAAC)Ceragenix Pharmaceuticals

Innovations & ideas, 7/2
Denver Post - A Denver-based biotechnology company is looking at ways to treat eczema in children without using steroids. Ceragenix Pharmaceuticals Inc. said last week that it will begin a study of its topical cream Epiceram to see if it works just as well on

Colorado business, 5/2
Denver Post - Ceragenix Pharmaceuticals Inc. , a Denver-based biopharmaceutical company, announced Monday that Steven Porter, its chairman and chief executive, will make a presentation at the Rodman & Renshaw third annual Global Healthcare Conference on May 15 in

Research on Use of Ceragenins(TM) As Potential Therapy for Cystic
MSN MoneyCentral - Ceragenix Pharmaceuticals, Inc. a biopharmaceutical company focused on infectious disease and dermatology, today announced that the American Society of Microbiology ("ASM") has accepted nine research abstracts on Ceragenins(TM) as poster

Innovations & ideas, 7/2
Denver Post - A Denver-based biotechnology company is looking at ways to treat eczema in children without using steroids. Ceragenix Pharmaceuticals Inc. said last week that it will begin a study of its topical cream Epiceram to see if it works just as well on

Ceragenix Pharmaceuticals, Inc. CEO Featured in Exclusive
MSN MoneyCentral - NEW YORK, July 13 /PRNewswire-FirstCall/ -- On July 12, Steven Porter, CEO of Ceragenix Pharmaceuticals, Inc. (OTC Bulletin Board: CGXP) updated the investment community in an exclusive interview with www.wallst.net . Topics covered in the interview

Ceragenix Pharmaceuticals, Inc. CEO Featured in Exclusive
MSN MoneyCentral - NEW YORK, July 13 /PRNewswire-FirstCall/ -- On July 12, Steven Porter, CEO of Ceragenix Pharmaceuticals, Inc. (OTC Bulletin Board: CGXP) updated the investment community in an exclusive interview with www.wallst.net . Topics covered in the interview

Colorado business, 5/2
Denver Post - Ceragenix Pharmaceuticals Inc. , a Denver-based biopharmaceutical company, announced Monday that Steven Porter, its chairman and chief executive, will make a presentation at the Rodman & Renshaw third annual Global Healthcare Conference on May 15 in

Innovations & ideas, 7/2
Denver Post - A Denver-based biotechnology company is looking at ways to treat eczema in children without using steroids. Ceragenix Pharmaceuticals Inc. said last week that it will begin a study of its topical cream Epiceram to see if it works just as well on

More trauma rooms permit family members' presence
KVOA 4 - NEW YORK, July 13 /PRNewswire-FirstCall/ -- On July 12, Steven Porter, CEO of Ceragenix Pharmaceuticals, Inc. updated the investment community in an exclusive interview with www.wallst.net . Topics covered in the interview include an overview of the

Colorado business, 5/2
Denver Post - Ceragenix Pharmaceuticals Inc. , a Denver-based biopharmaceutical company, announced Monday that Steven Porter, its chairman and chief executive, will make a presentation at the Rodman & Renshaw third annual Global Healthcare Conference on May 15 in

Innovations & ideas, 7/2
Denver Post - A Denver-based biotechnology company is looking at ways to treat eczema in children without using steroids. Ceragenix Pharmaceuticals Inc. said last week that it will begin a study of its topical cream Epiceram to see if it works just as well on